NEW YORK (GenomeWeb Daily News) – The Southwest Michigan First Life Science Fund said this week that it has invested an undisclosed amount in RealBio Technology to support the commercialization of its cell and tissue culture technology for drug discovery and life science research.

Other investors include stem-cell therapy firm Aastrom Biosciences and First Angels, a Kalamazoo-based angel investor group. RealBio also has received funding from the Michigan Pre-Seed Microloan Program.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.